colonoscopy and semaglutide GLP-1 weight-loss meds could interfere with endoscopy, Semaglutide Colonoscopy Prep: Provider Guidance

Description

Eli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the companys tirzepatide (Mounjaro) compared with Novo Nordisks semaglutide (Wegovy) 2.4mg in 700 adult participants who have obesity or overweight with weight related comorbidities without Type 2 diabetes

Bridging the gap between guidelines and practice will require systemic interventions, including physician training, patient-centered care models, and devising research strategies such as national HF registries to understand and tailor therapeutic approaches from an Indian perspective.

Call now to support weight loss, wellness, and renewed vitality!

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.